Andrew George

Andrew George is Deputy Vice-Chancellor (Education and International) of Brunel University. He joined Brunel from Imperial College London where he was Professor of Molecular Immunology and Director of the Graduate School and the School of Professional Development.

Andrew George did his first degree at the University of Cambridge, before going on to the Tenovus Laboratories in the University of Southampton to do his PhD with Professor Freda Stevenson, developing a vaccine for B cell lymphoma. He was awarded a Beit Memorial Fellowship and stayed in Southampton for his first postdoctoral period, before going to Dr David Segal’s laboratory in the National Institutes of Health (NIH), Bethesda, USA, where he used recombinant techniques to generate novel antibody molecules. In 1992 he returned to the UK as a lecturer at the Royal Postgraduate Medical School, Hammersmith Hospital, which merged with Imperial College in 1997.

Andrew’s research has sought to understand and manipulate the immune system in order to treat disease, in particular to prevent the rejection of transplanted organs. He has also used mathematical models to understand how the immune system functions. In addition to his research, he has been involved in the ethical conduct and regulation of research. He is currently Chair of the UK’s National Research Ethics Advisors’ Panel and is on the Clinical Trials, Biologicals and Vaccines Expert Advisory Group for the Commission of Human Medicines/MHRA. He is a Governor of Richmond Adult Community College and the John Hampden School.



Andrew George | 20 Feb 2016 |
tags: clinical ethics, clinical trials, history of bioethics, history of medicine, informed consent
A single vulnerable subject exposed to a dread disease without animal trials -- it's not sounding good
 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Recent Posts
Alabama passes most restrictive abortion law in US
19 May 2019
Ontario appeals court affirms right of state to compel participation in euthanasia  
19 May 2019
4-year-old can begin transgender transition, says UK court
19 May 2019
Are performance-reducing drugs for South African Olympian Caster Semenya ethical?
19 May 2019
Belgian doctors target vegan parents as abusive
19 May 2019

 Archive
May 2019 | Apr 2019 | Mar 2019 | more >>

Home | About Us | Contact Us | rss RSS | Archive | Bookmark and Share | michael@bioedge.org

BioEdge - New Media Foundation Ltd © 2004 - 2019